APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Coagulants

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Blood Coagulants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025180 pages

Choose your research edition.

Industry ResearchBlood Coagulants Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Coagulants Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Blood Coagulants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Coagulants Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Coagulants Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Blood Coagulants market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Blood Coagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood Coagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Coagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Blood Coagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blood Coagulants include Takeda, Novo Nordisk, Pfizer, Bayer, SOBI, Octapharma and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Blood Coagulants market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Coagulants and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Coagulants sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blood Coagulants market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood Coagulants Segment by Company

Takeda

Novo Nordisk

Pfizer

Bayer

SOBI

Octapharma

CSL

Blood Coagulants Segment by Type

Recombinant Coagulation Factor

Plasma Coagulation Factor

Blood Coagulants Segment by Application

Hospital

Pharmacy

Other

Blood Coagulants Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Coagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Coagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Coagulants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Blood Coagulants market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Blood Coagulants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Blood Coagulants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Blood Coagulants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Blood Coagulants Industry Trends Table 2. Blood Coagulants Industry Drivers Table 3. Blood Coagulants Industry Opportunities and Challenges Table 4. Blood Coagulants Industry Restraints Table 5. Global Blood Coagulants Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Blood Coagulants Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Blood Coagulants Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Blood Coagulants Sales Market Share by Manufacturers Table 9. Global Blood Coagulants Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Blood Coagulants Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Blood Coagulants Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Blood Coagulants Manufacturers, Product Type & Application Table 13. Global Blood Coagulants Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Blood Coagulants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Recombinant Coagulation Factor Table 17. Major Manufacturers of Plasma Coagulation Factor Table 18. Global Blood Coagulants Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Blood Coagulants Sales by Type (2021-2026) & (K Units) Table 20. Global Blood Coagulants Sales by Type (2027-2032) & (K Units) Table 21. Global Blood Coagulants Sales Market Share by Type (2021-2026) Table 22. Global Blood Coagulants Sales Market Share by Type (2027-2032) Table 23. Global Blood Coagulants Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Blood Coagulants Revenue by Type (2021-2026) & (K Units) Table 25. Global Blood Coagulants Revenue by Type (2027-2032) & (K Units) Table 26. Global Blood Coagulants Revenue Market Share by Type (2021-2026) Table 27. Global Blood Coagulants Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Other Table 31. Global Blood Coagulants Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Blood Coagulants Sales by Application (2021-2026) & (K Units) Table 33. Global Blood Coagulants Sales by Application (2027-2032) & (K Units) Table 34. Global Blood Coagulants Sales Market Share by Application (2021-2026) Table 35. Global Blood Coagulants Sales Market Share by Application (2027-2032) Table 36. Global Blood Coagulants Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Blood Coagulants Revenue by Application (2021-2026) & (K Units) Table 38. Global Blood Coagulants Revenue by Application (2027-2032) & (K Units) Table 39. Global Blood Coagulants Revenue Market Share by Application (2021-2026) Table 40. Global Blood Coagulants Revenue Market Share by Application (2027-2032) Table 41. Global Blood Coagulants Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Blood Coagulants Sales by Region (2021-2026) & (K Units) Table 43. Global Blood Coagulants Sales Market Share by Region (2021-2026) Table 44. Global Blood Coagulants Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Blood Coagulants Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Blood Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Blood Coagulants Sales by Country (2021-2026) & (K Units) Table 48. North America Blood Coagulants Sales by Country (2027-2032) & (K Units) Table 49. Europe Blood Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Blood Coagulants Sales by Country (2021-2026) & (K Units) Table 51. Europe Blood Coagulants Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Blood Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Blood Coagulants Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Blood Coagulants Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Blood Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Blood Coagulants Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Blood Coagulants Sales by Country (2027-2032) & (K Units) Table 58. Global Blood Coagulants Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Blood Coagulants Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Blood Coagulants Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Blood Coagulants Revenue Market Share by Region (2021-2026) Table 62. Global Blood Coagulants Revenue Market Share by Region (2027-2032) Table 63. Takeda Company Information Table 64. Takeda Business Overview Table 65. Takeda Blood Coagulants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Takeda Blood Coagulants Product Portfolio Table 67. Takeda Recent Development Table 68. Novo Nordisk Company Information Table 69. Novo Nordisk Business Overview Table 70. Novo Nordisk Blood Coagulants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novo Nordisk Blood Coagulants Product Portfolio Table 72. Novo Nordisk Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Blood Coagulants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pfizer Blood Coagulants Product Portfolio Table 77. Pfizer Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Blood Coagulants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bayer Blood Coagulants Product Portfolio Table 82. Bayer Recent Development Table 83. SOBI Company Information Table 84. SOBI Business Overview Table 85. SOBI Blood Coagulants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. SOBI Blood Coagulants Product Portfolio Table 87. SOBI Recent Development Table 88. Octapharma Company Information Table 89. Octapharma Business Overview Table 90. Octapharma Blood Coagulants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Octapharma Blood Coagulants Product Portfolio Table 92. Octapharma Recent Development Table 93. CSL Company Information Table 94. CSL Business Overview Table 95. CSL Blood Coagulants Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. CSL Blood Coagulants Product Portfolio Table 97. CSL Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Blood Coagulants Distributors List Table 101. Blood Coagulants Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Blood Coagulants Product Image Figure 2. Global Blood Coagulants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Coagulants Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Coagulants Sales (2021-2032) & (K Units) Figure 5. Global Blood Coagulants Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Blood Coagulants Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Recombinant Coagulation Factor Image Figure 9. Plasma Coagulation Factor Image Figure 10. Global Blood Coagulants Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Blood Coagulants Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Blood Coagulants Sales Market Share by Type (2021-2032) Figure 13. Global Blood Coagulants Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Blood Coagulants Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Blood Coagulants Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Pharmacy Image Figure 18. Other Image Figure 19. Global Blood Coagulants Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Blood Coagulants Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Blood Coagulants Sales Market Share by Application (2021-2032) Figure 22. Global Blood Coagulants Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Blood Coagulants Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Blood Coagulants Revenue Market Share by Application (2021-2032) Figure 25. North America Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Blood Coagulants Sales Market Share by Country (2021-2032) Figure 27. U.S. Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Blood Coagulants Sales Market Share by Country (2021-2032) Figure 32. Germany Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Blood Coagulants Sales Market Share by Country (2021-2032) Figure 39. China Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Blood Coagulants Sales Market Share by Country (2021-2032) Figure 47. Brazil Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Blood Coagulants Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Blood Coagulants Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Blood Coagulants Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Blood Coagulants Revenue (2021-2032) & (US$ Million) Figure 58. North America Blood Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Blood Coagulants Revenue (2021-2032) & (US$ Million) Figure 60. Europe Blood Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Blood Coagulants Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Blood Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Blood Coagulants Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Blood Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Blood Coagulants Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Blood Coagulants Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Coagulation Factor
  • Plasma Coagulation Factor
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Takeda
  • Novo Nordisk
  • Pfizer
  • Bayer
  • SOBI
  • Octapharma
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Blood Coagulants Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Blood Coagulants Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Blood Coagulants Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Blood Coagulants Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Blood Coagulants Market Dynamics
  1. 2.1 Blood Coagulants Industry Trends
  2. 2.2 Blood Coagulants Industry Drivers
  3. 2.3 Blood Coagulants Industry Opportunities and Challenges
  4. 2.4 Blood Coagulants Industry Restraints
3 Blood Coagulants Market by Manufacturers
  1. 3.1 Global Blood Coagulants Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Blood Coagulants Sales by Manufacturers (2021-2026)
  3. 3.3 Global Blood Coagulants Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Blood Coagulants Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Blood Coagulants Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Blood Coagulants Manufacturers, Product Type & Application
  7. 3.7 Global Blood Coagulants Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Blood Coagulants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Blood Coagulants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Blood Coagulants Tier 1, Tier 2, and Tier 3
4 Blood Coagulants Market by Type
  1. 4.1 Blood Coagulants Type Introduction
  2. 4.1.1 Recombinant Coagulation Factor
  3. 4.1.2 Plasma Coagulation Factor
  4. 4.2 Global Blood Coagulants Sales by Type
  5. 4.2.1 Global Blood Coagulants Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Blood Coagulants Sales by Type (2021-2032)
  7. 4.2.3 Global Blood Coagulants Sales Market Share by Type (2021-2032)
  8. 4.3 Global Blood Coagulants Revenue by Type
  9. 4.3.1 Global Blood Coagulants Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Blood Coagulants Revenue by Type (2021-2032)
  11. 4.3.3 Global Blood Coagulants Revenue Market Share by Type (2021-2032)
5 Blood Coagulants Market by Application
  1. 5.1 Blood Coagulants Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Blood Coagulants Sales by Application
  6. 5.2.1 Global Blood Coagulants Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood Coagulants Sales by Application (2021-2032)
  8. 5.2.3 Global Blood Coagulants Sales Market Share by Application (2021-2032)
  9. 5.3 Global Blood Coagulants Revenue by Application
  10. 5.3.1 Global Blood Coagulants Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Blood Coagulants Revenue by Application (2021-2032)
  12. 5.3.3 Global Blood Coagulants Revenue Market Share by Application (2021-2032)
6 Global Blood Coagulants Sales by Region
  1. 6.1 Global Blood Coagulants Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Coagulants Sales by Region (2021-2032)
  3. 6.2.1 Global Blood Coagulants Sales by Region (2021-2026)
  4. 6.2.2 Global Blood Coagulants Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Blood Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Blood Coagulants Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Blood Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Blood Coagulants Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Blood Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Blood Coagulants Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Blood Coagulants Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Blood Coagulants Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Blood Coagulants Revenue by Region
  1. 7.1 Global Blood Coagulants Revenue by Region
  2. 7.1.1 Global Blood Coagulants Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Blood Coagulants Revenue by Region (2021-2026)
  4. 7.1.3 Global Blood Coagulants Revenue by Region (2027-2032)
  5. 7.1.4 Global Blood Coagulants Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Blood Coagulants Revenue (2021-2032)
  8. 7.2.2 North America Blood Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Blood Coagulants Revenue (2021-2032)
  11. 7.3.2 Europe Blood Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Blood Coagulants Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Blood Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Blood Coagulants Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Blood Coagulants Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Blood Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Blood Coagulants Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Novo Nordisk
  8. 8.2.1 Novo Nordisk Company Information
  9. 8.2.2 Novo Nordisk Business Overview
  10. 8.2.3 Novo Nordisk Blood Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novo Nordisk Blood Coagulants Product Portfolio
  12. 8.2.5 Novo Nordisk Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Blood Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Blood Coagulants Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Blood Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Blood Coagulants Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 SOBI
  26. 8.5.1 SOBI Company Information
  27. 8.5.2 SOBI Business Overview
  28. 8.5.3 SOBI Blood Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SOBI Blood Coagulants Product Portfolio
  30. 8.5.5 SOBI Recent Developments
  31. 8.6 Octapharma
  32. 8.6.1 Octapharma Company Information
  33. 8.6.2 Octapharma Business Overview
  34. 8.6.3 Octapharma Blood Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Octapharma Blood Coagulants Product Portfolio
  36. 8.6.5 Octapharma Recent Developments
  37. 8.7 CSL
  38. 8.7.1 CSL Company Information
  39. 8.7.2 CSL Business Overview
  40. 8.7.3 CSL Blood Coagulants Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CSL Blood Coagulants Product Portfolio
  42. 8.7.5 CSL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Blood Coagulants Value Chain Analysis
  2. 9.1.1 Blood Coagulants Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Blood Coagulants Production Mode & Process
  6. 9.2 Blood Coagulants Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Blood Coagulants Distributors
  9. 9.2.3 Blood Coagulants Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst